Blog

Scientists Just Discovered the #1 Vitamin to Protect Your Vision

Top Vitamin to Safeguard Your Eyesight, Says New Study Maintaining healthy eyesight is crucial for overall well-being, yet many people overlook the role of nutrition in protecting their vision. A new study has identified a key vitamin that plays a vital role in safeguarding eye health and preventing age-related vision problems. Whether you spend hours […]

Scientists Just Discovered the #1 Vitamin to Protect Your Vision Read More »

Best Life: Can good cholesterol actually be bad for glaucoma?

Can Good Cholesterol Harm Your Glaucoma Risk? For years, high-density lipoprotein (HDL), often referred to as “good cholesterol,” has been celebrated for its role in heart health. It helps remove low-density lipoprotein (LDL), or “bad cholesterol,” from the bloodstream, reducing the risk of cardiovascular disease. But could there be a downside to having high HDL

Best Life: Can good cholesterol actually be bad for glaucoma? Read More »

A Case of Corneal Endothelial Cell Loss After PreserFlo MicroShunt Implantation Requiring Device Removal and Ahmed Glaucoma Valve Implantation With Tube Insertion Into the Vitreous Cavity

PreserFlo MicroShunt Complications Lead to Corneal Damage and Surgical Revision The PreserFlo MicroShunt has been widely adopted as a minimally invasive surgical option for glaucoma patients, offering an alternative to traditional trabeculectomy. While the device has shown promise in reducing intraocular pressure (IOP), emerging reports highlight complications such as corneal damage and the need for

A Case of Corneal Endothelial Cell Loss After PreserFlo MicroShunt Implantation Requiring Device Removal and Ahmed Glaucoma Valve Implantation With Tube Insertion Into the Vitreous Cavity Read More »

Correlation of optic nerve hemoglobin levels with structural and functional parameters in glaucoma

Optic Nerve Hemoglobin Levels Impact Glaucoma Structure and Function Glaucoma is a leading cause of irreversible blindness worldwide, characterized by progressive damage to the optic nerve and retinal ganglion cells. While elevated intraocular pressure (IOP) has long been recognized as a major risk factor, emerging research suggests that optic nerve hemoglobin levels may play a

Correlation of optic nerve hemoglobin levels with structural and functional parameters in glaucoma Read More »

Glaucoma Treatment Market Booms to USD 14.1 Billion by 2033: A 5.35% CAGR Forecast

Glaucoma Treatment Market to Hit USD 14.1 Billion by 2033 with 5.35% CAGR Growth The global glaucoma treatment market is poised for significant expansion, projected to reach USD 14.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.35%. This growth is fueled by rising prevalence of glaucoma, advancements in treatment options,

Glaucoma Treatment Market Booms to USD 14.1 Billion by 2033: A 5.35% CAGR Forecast Read More »

Brandon Capital, Labor’s NRF invest $40m into glaucoma biotech PolyActiava

Brandon Capital and Labor’s NRF Invest $40M in Glaucoma Biotech PolyActiva The biotechnology sector continues to attract significant investment as innovative companies push the boundaries of medical science. In a major development, Brandon Capital and Labor’s National Reconstruction Fund (NRF) have jointly invested $40 million in PolyActiva, an Australian biotech firm specializing in glaucoma treatments.

Brandon Capital, Labor’s NRF invest $40m into glaucoma biotech PolyActiava Read More »

Cases of ‘three major eye diseases’ linked to blindness surge

Surge in Three Major Eye Diseases Linked to Blindness In recent years, the prevalence of eye diseases leading to blindness has seen a concerning rise. With aging populations, increased screen time, and environmental factors, experts warn that conditions like glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy are becoming more widespread. Understanding these diseases, their

Cases of ‘three major eye diseases’ linked to blindness surge Read More »

Scroll to Top